We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 11th:
ACI Worldwide, Inc. (ACIW - Free Report) : This provider of payment software products and services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.
Avinger, Inc. (AVGR - Free Report) : This designer and manufacturer of image-guided and catheter-based systems has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.3% over the last 60 days.
Acacia Communications, Inc. : This developer and manufacturer of high-speed coherent optical interconnect products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for April 11th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 11th:
ACI Worldwide, Inc. (ACIW - Free Report) : This provider of payment software products and services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.
ACI Worldwide, Inc. Price and Consensus
ACI Worldwide, Inc. price-consensus-chart | ACI Worldwide, Inc. Quote
AAON's shares gained 5.2% over the last one month more than S&P 500’s gain of 3.8%. The company possesses a Momentum Score of B.
ACI Worldwide, Inc. Price
ACI Worldwide, Inc. price | ACI Worldwide, Inc. Quote
Avinger, Inc. (AVGR - Free Report) : This designer and manufacturer of image-guided and catheter-based systems has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.3% over the last 60 days.
Avinger, Inc. Price and Consensus
Avinger, Inc. price-consensus-chart | Avinger, Inc. Quote
Avinger's shares gained 29.7% over the last one month. The company possesses a Momentum Score of A.
Avinger, Inc. Price
Avinger, Inc. price | Avinger, Inc. Quote
Acacia Communications, Inc. : This developer and manufacturer of high-speed coherent optical interconnect products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
Acacia Communications, Inc. Price and Consensus
Acacia Communications, Inc. price-consensus-chart | Acacia Communications, Inc. Quote
Acacia Communications' shares gained 11.1% over the last one month. The company possesses a Momentum Score of B.
Acacia Communications, Inc. Price
Acacia Communications, Inc. price | Acacia Communications, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>